What does identity confirmation by mass spectrometry add for survodutide that a purity figure does not?

Stated plainly: identity confirmation by mass spectrometry · survodutide.

I am trying to choose between two options that are usually discussed as though only one exists.

I am not optimising for price, but I am not indifferent to it either.

What does each option buy me, and what does it cost me?

The short answer is that purity says "what fraction of detected material is the target" while content says "how many milligrams of the target are present," and those are two different things.

For peptides at 214 nanometres the response is roughly proportional to the number of peptide bonds, so truncation impurities have lower response factors and overestimate content.

Specifically, if a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.

Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.

One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.

If a supplier gives you content without the standard's purity, ask them to provide it.

Reading a content result requires knowing the purity of the standard against which the sample was quantified, because your result inherits that uncertainty.

Peak area for a standard of known weight produces a response factor — area per unit mass — which is then applied to the sample peak to infer sample mass.

Stated carefully, running multiple independent aliquots of the same sample should give results that agree to within the method precision, which is usually one to three per cent.

The caveat is that content assay costs more than purity, so most people do not do it, which is exactly why it is valuable on the first lot from a new supplier.

Ask for both the purity and the content, and do not accept purity alone.

More usefully, a high purity does not guarantee high content because it says nothing about how much of anything is in the vial — a vial could be 99 per cent pure but only half full.

Comparing content results from different laboratories requires knowing whether they both used certified reference materials or whether one used an in-house standard of unknown provenance.

Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.

The limitation is that a quantitative method is only as good as the standard it uses, and a cheap standard is a false economy.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

The underlying point is that quantified content is how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard, and it is the only measurement that directly answers that question.

If the standard and sample have different absorption coefficients at the detection wavelength, the response factors differ and the inference fails.

The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.